Thank you for your helpful and insightful comments. Don't stop now, tell us everything little thing that passes through your cranium.
That's what everyone says, but I've never seen any evidence. We know that he doesn't trade personally. Anytime some people lose money on the stock market, they start blaming Cramer, the market maker, Goldman Sachs, and so on and so on. The fact is that no one can predict the future. Cramer's predictions don't always do well.
I agree with rationalthought. Anyone who is concerned about money has no business trading securities. This is a gentlemen's club for entertainment only.
At least we can sell call options on our BRCM and EMC holdings and watch the time value disappear with little chance of being in the money at expiration.
The Feds are keeping interest rates down, which means that bonds pay very little. But BIV is mainly Treasury bonds, which will go up in price if the stock market tanks. So they are a good hedge against a market downturn, and a good place to keep your money if you don't want to buy into the stock market right now.
It's true that bond prices are vulnerable to inflation, which is a valid long-term concern; but for the next year or so, the economy is so weak that people just aren't spending a lot of money. No matter how many bonds the Feds buy, until the so-called "velocity" (i.e., spending) of money picks up, inflation will be kept in check.
Between posting on this message board and your street signs, you have my every confidence that you will single-handedly raise ACI's price to $9.38
The price for this company is directly levered to the prospects of Romney for pres. With unemployment numbers down today (10/5), Obama's election prospects look better, and ACI's price drops.
You don't need a bookie to bet on the presidential election, just buy or short ACI depending on which candidate you think will win! If Romney wins, a price double is assured in the short term.
Apparently, there were almost no shares available to trade, as most traders couldn't sell their shares until they were issued new post-split shares, which took about a week. Now that the stock is liquid again, we can expect the price to go back to what it was pre-split, about $4.80 (in split-adjusted terms). The NASDAQ listing is good news, but not that good.
We've gone from .22 to .54 in six days. The only news seems to be the recent financing agreement http://biz.yahoo.com/e/120720/nwbo8-k.html. Uncertainty regarding financing, the possibility of dilution, was holding the stock price down. Now that financing is in place, the price has more than doubled.
The fact is that most patients who have received the treatment have survived much longer than average. If there were "no real conclusions" to be drawn, the drug wouldn't be approved for further testing. True, the drug isn't yet approved for sale on the market, but any patient with this cancer would obviously be eager to take it.
Apparently a lot of people have sold on Adam Feurerstein's article for The Street. He says that IMUC's excellent results aren't meaningful because they didn't use a control group who only received a placebo.
That might be true if you're testing a drug for something like the flu or back-pain, situations where many people get well spontaneously. But with cancer in general, and especially brain cancer, patients simply do not get well spontaneously. If patient's survival rate after taking the drug is better than the historical average, then the results are significant. The de facto "control group" is everything we know about the survival rates of people who have this form of cancer, and there is in fact a lot of information in this regard. As IMUC goes to the next level of testing, they will probably start including a control group in their testing, but for initial tests it's not necessary.